Facing the Facts of Altered Plasma Protein Binding: Do Current Models Correctly Predict Changes in Fraction Unbound in Special Populations?-Reference-Cited by-同舟云学术

Facing the Facts of Altered Plasma Protein Binding: Do Current Models Correctly Predict Changes in Fraction Unbound in Special Populations?

Published:2024-06 Issue:6 Volume:113 Page:1664-1673
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Al-Qassabi Jokha,Tan Shawn Pei Feng^ORCID,Phonboon Patcharapan^ORCID,Galetin Aleksandra^ORCID,Rostami-Hodjegan Amin^ORCID,Scotcher Daniel^ORCID

Funder

Ministry of Higher Education, Research and Innovation

Agency for Science, Technology and Research

Publisher

Elsevier BV

Reference50 articles.

1. Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry (DRAFT GUIDANCE),2019

2. Drug dosing recommendations for all patients: a roadmap for change;Powell;Clin Pharmacol Ther,2021

3. Physiological-based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20-years; in-depth analysis of applications, organizations, and platforms;El-Khateeb;Biopharm Drug Dispos,2021

4. Physiologically-based pharmacokinetic modeling in renal and hepatic impairment populations: a pharmaceutical industry perspective;Heimbach;Clin Pharmacol Ther,2021

5. Determining the Glomerular Filtration Rate-An Overview;Schaeffner;J Ren Nutr,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding plasma protein binding of drugs: Considering complexity and binding dynamics;Journal of Pharmaceutical Sciences;2024-09

2. Disposition of Oral Nalbuphine and Its Metabolites in Healthy Subjects and Subjects with Hepatic Impairment: Preliminary Modeling Results Using a Continuous Intestinal Absorption Model with Enterohepatic Recirculation;Metabolites;2024-08-27

3. Predicting plasma protein binding of drugs in special populations: Are all models wrong, but can some be recalibrated, refined, and become more useful?;Journal of Pharmaceutical Sciences;2024-08

4. Dosing Adjustments in Cases of Altered Plasma Protein Binding are Most Needed for Drugs with a Volume of Distribution Below 1.3 L/kg;Clinical Pharmacokinetics;2024-07-24

5. Phase 1 pharmacokinetic and safety study of soticlestat in participants with mild or moderate hepatic impairment or normal hepatic function;Pharmacology Research & Perspectives;2024-07-11